Clinical Trials in Hanzhou, China
4 recruiting
Showing 1–20 of 24 trials
Recruiting
Phase 1
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd.130 enrolled11 locationsNCT06375044
Recruiting
Not Applicable
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
Schizophrenia
Sir Run Run Shaw Hospital100 enrolled2 locationsNCT06470516
Recruiting
Phase 3
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-small Cell Lung Cancer
Summit Therapeutics1,600 enrolled244 locationsNCT05899608
Recruiting
Phase 1Phase 2
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.121 enrolled2 locationsNCT06590246
Recruiting
Phase 3
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd400 enrolled87 locationsNCT06079983
Recruiting
Phase 1
Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Advanced Solid Tumors
First Affiliated Hospital of Zhejiang University98 enrolled1 locationNCT04778839
Recruiting
Phase 1Phase 2
A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma
Relapsed/Refractory Primary Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University38 enrolled1 locationNCT06556199
Recruiting
Phase 3
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer
Rectal Cancer
Sir Run Run Shaw Hospital170 enrolled1 locationNCT06507371
Recruiting
Phase 1Phase 2
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
Acute Myeloid Leukemia, Adult
Sunshine Lake Pharma Co., Ltd.133 enrolled1 locationNCT05133882
Recruiting
Phase 3
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
Leukemia Acute Myeloid - AML
Sunshine Lake Pharma Co., Ltd.324 enrolled1 locationNCT05586074
Recruiting
Phase 1
Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL
B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University48 enrolled1 locationNCT05472558
Recruiting
Phase 2
GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence
Intrahepatic Cholangiocarcinoma
Zhejiang Cancer Hospital20 enrolled2 locationsNCT05557578
Recruiting
Phase 2
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Ovarian CancerEndometrial CancerPrimary Peritoneal Cancer+1 more
Hansoh BioMedical R&D Company460 enrolled28 locationsNCT06014190
Recruiting
Phase 1Phase 2
A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma
PCNSL
Second Affiliated Hospital, School of Medicine, Zhejiang University43 enrolled1 locationNCT06554561
Recruiting
Phase 2
A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma
Refractory or Relapsed Diffuse Large B Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University36 enrolled1 locationNCT06554600
Recruiting
Not Applicable
The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study
Schizophrenia
Sir Run Run Shaw Hospital12 enrolled1 locationNCT06231732
Recruiting
Not Applicable
Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer
Colorectal, Cancer
Sir Run Run Shaw Hospital990 enrolled1 locationNCT06167967
Recruiting
Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration
Locally Advanced Gastric Carcinoma
Zhejiang University120 enrolled4 locationsNCT06396143
Recruiting
Phase 3
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
Breast CancerChemotherapy Effect
Second Affiliated Hospital, School of Medicine, Zhejiang University400 enrolled1 locationNCT05212454
Recruiting
Phase 3
Study of Comparing of With and Without Sequential Therapy of S-1
Locally Advanced Gastric AdenocarcinomaChemotherapy Effect
Zhejiang University70 enrolled1 locationNCT05813015